Picture of Addex Therapeutics logo

ADXN Addex Therapeutics News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Addex Therapeutics Q3 Net Loss At 3.3 Mln CHF

Nov 3 (Reuters) - ADDEX THERAPEUTICS LTD  ADXN.S :
    * Q3 NET LOSS -3.3 MILLION CHF
    * Q3 DILUTED EPS LOSS 0.12 CHF VERSUS 0.14 CHF LOSS YEAR AGO
    * INCOME DECREASED BY CHF 0.4 MILLION TO CHF 0.1 MILLION IN
Q3
2020, COMPARED TO CHF 0.5 MILLION IN Q3 2019
    * RESEARCH AND DEVELOPMENT COSTS DECREASED BY CHF 0.9
MILLION TO
CHF 2.0 MILLION IN Q3 2020 COMPARED TO Q3 2019
    * NET LOSS DECREASED BY CHF 0.3 MILLION TO CHF 3.3 MILLION
IN Q3
2020 COMPARED TO Q3 2019 AND CHF 0.4 MILLION TO CHF 10.8 MILLION
FOR NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2020

Source text for Eikon:  ID:nGNE4c3J0M 
Further company coverage:  ADXN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Addex Therapeutics

See all news